We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Qualyst and Solvo Biotechnology Announce Alliance for B CLEAR® in Europe
News

Qualyst and Solvo Biotechnology Announce Alliance for B CLEAR® in Europe

Qualyst and Solvo Biotechnology Announce Alliance for B CLEAR® in Europe
News

Qualyst and Solvo Biotechnology Announce Alliance for B CLEAR® in Europe

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Qualyst and Solvo Biotechnology Announce Alliance for B CLEAR® in Europe"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Solvo Biotechnology and Qualyst, Inc. have announced that Solvo has obtained a license to Qualyst’s B CLEAR® system. B-CLEAR® products and services are projected to be available in Europe from Solvo in early 2008.  Financial details were not disclosed.

B-CLEAR® is a patented system for the in vitro assessment and in vivo prediction of hepatobiliary disposition, hepatic uptake, hepatic efflux, biliary clearance and drug transport. B-CLEAR® offers research organizations the ability to generate physiologically-relevant data and enable decision making in critical areas related to hepatic transport and adverse drug interactions, helping to avoid costly drug development challenges.

B-CLEAR® can be used as an early discovery screen for promotion of compounds, as a source of lead optimization guidance, and as a tool to address development-stage drug transport and drug-drug interaction challenges.

Advertisement